Provided by Tiger Fintech (Singapore) Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

16.77
-0.5900-3.40%
Volume:12.87K
Turnover:217.62K
Market Cap:5.67B
PE:187.40
High:17.19
Open:16.72
Low:16.31
Close:17.36
Loading ...

Telix Pharmaceuticals Reports Robust Financial Growth in 2024

TIPRANKS
·
20 Feb

Telix Pharmaceuticals’ Illuccix Approved in UK, Enhancing Prostate Cancer Management

TIPRANKS
·
13 Feb

Is Telix Pharmaceuticals Limited (TLX) the Best Long Term ASX Stock to Buy Now?

Insider Monkey
·
12 Feb

Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF) and Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF)

TIPRANKS
·
04 Feb

Telix Pharmaceuticals Compeletes Acquisition of US-Based Biotech Company; Shares Hit All-Time High

MT Newswires Live
·
31 Jan

Telix Pharmaceuticals Announces Quotation of New Securities

TIPRANKS
·
31 Jan

Telix Pharmaceuticals Expands Pipeline with ImaginAb Acquisition

TIPRANKS
·
31 Jan

Buy Rating for Telix Pharmaceuticals Ltd. Supported by Strong Financials and Growth Potential

TIPRANKS
·
29 Jan

Telix Pharmaceuticals Completes Acquisition of RLS

MT Newswires Live
·
28 Jan

UBS Adjusts Price Target on Telix Pharmaceuticals to $22 From $21, Keeps Buy Rating

MT Newswires Live
·
27 Jan

Telix Pharmaceuticals Receives Positive Decision on Marketing Application in Europe; Shares Hit All-Time High

MT Newswires Live
·
17 Jan

Telix Pharmaceuticals Secures Marketing Approval for Illuccix in Europe

MT Newswires Live
·
17 Jan

Illuccix® Receives European Approval

GlobeNewswire
·
17 Jan

Telix Pharmaceuticals’ Illuccix Gains European Marketing Authorization

TIPRANKS
·
17 Jan

Telix Pharmaceuticals (TLX) Shares Soar on FY24 Success

TIPRANKS
·
14 Jan

Telix Pharmaceuticals' Revenue Surges 46% in Q4; Full-Year Revenue Beats Guidance

MT Newswires Live
·
14 Jan

Telix Pharmaceuticals to Acquire Assets of ImaginAb for $45 Million

MT Newswires Live
·
13 Jan

Telix Pharma Reported Q4 Revenue Of $142M, Up 46% YoY, FY24 Revenue Of $517M, Up By 55% YoY

Benzinga
·
13 Jan

Telix Exceeds FY24 Guidance with US$142M Q4 Revenue

GlobeNewswire
·
13 Jan

Telix Pharmaceuticals Showcases Radiopharma Innovations at Healthcare Conference

TIPRANKS
·
13 Jan